Victor Kleinman is a Senior Partner with Kingsley Gate Partners. Previously he served as Managing Partner of the Global Biopharmaceutical Practice for a global retained executive search firm. His career in Life Sciences executive search and organizational consulting spans three decades. Victor has established an international reputation for consultative, relationship driven, performance-based project management during this tenure. Victor’s client base includes multiple “top-ten” global pharmaceutical companies, midsized biopharmaceutical companies and smaller, emerging companies. On their behalf, he has successfully recruited highly prominent, game-changing leaders who have developed and commercialized next-generation therapies in Oncology, Cardiovascular/Metabolic Medicine, Neuroscience, Immunology, Respiratory and Rare/Orphan diseases.
Victor also has long standing relationships and deep expertise working with the world’s leading medical device and diagnostic companies, including significant work more recently in the expanding arena of companion diagnostics. Victor and his Kingsley Gate Partners Life Sciences colleagues have decades of combined experience in some of the Industry’s most demanding functional areas including, but not limited to, Translational/Experimental Medicine, Clinical Development, Regulatory Affairs, Quality, Manufacturing/CMC, Global Project Management, Global Development, Chief Commercial Officers, Chief Medical Officers, CEO’s and Board Members. He presents a legacy of success in recruiting senior leaders who have developed and commercialized numerous revolutionary blockbuster drugs, products and medical technologies. He has also worked closely with many early-stage companies in the recruitment of senior leadership teams, extending his involvement and collaboration across every stage of organizational growth, including successful IPOs and product approval/product launches. Victor is a respected thought leader and has been frequently quoted in Business Insider, Life Science Leader, Bio World Insight, Fierce Biotech, STAT and other industry news and information sources.